Seaport Therapeutics
United States · $340.0M raised
- Website
- seaporttx.com
- Total Funding
- $340.0M
- Last Round
- $15.0M GrantMar 2026
- Rounds
- 3
About
Seaport Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric medicines in areas of unmet patient needs.
Summary
Seaport Therapeutics is a Life Sciences company based in United States. It has raised $340.0M in total across 3 rounds, most recently a $15.0M Grant round in Mar 2026. Investors include General Atlantic, ARCH Venture Partners and Sofinnova Investments.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.